Literature DB >> 34249446

TAFs contributes the function of PTPN2 in colorectal carcinogenesis through activating JAK/STAT signaling pathway.

Wei Zhao1,2, Lei Hao3, Lizhou Jia1,4, Jinsong Wang2, Bin Wang2, Yanqiang Huang1, Youcai Zhao2.   

Abstract

The morbidity and mortality of colorectal cancer (CRC) ranks fourth worldwide, moreover, the tumor microenvironment (TME) of CRC is quite complex, and is one of the necessary factors affecting promotion of tumor metastasis. PTPN2 is a tumor suppressor which plays an important role in cancer-related downstream molecular pathway. FSP-1 is highly-expressed in multiple types of tumor tissues and is a biomarker of stromal fibroblasts. To examine the function of PTPN2 in the metastasis of CRC, the study evaluated the co-expression level of PTPN2 and FSP-1 in CRC tissues by double staining, and demonstrated the relationship with clinical information about each patient. The roles of PTPN2 and FSP-1 were detected in vitro by proliferation and transwell assay through knockdown of expression level of PTPN2. Lower PTPN2 with higher FSP-1 expression was correlated with poor survival outcomes in CRC. TAFs contribute to the migration function of PTPN2 in CRC in vitro through inducing changes in the level of TGF-β1. Western blot and qRT-PCR assays were used to detect the mechanism of PTPN2 regulation of migration with TAFs in the JAK/STAT signaling pathway, moreover, TAFs contributed the function of PTPN2 in colorectal carcinogenesis in vivo. In summary, the study shed light on the effect of TAFs contributes the function of PTPN2 in colorectal carcinogenesis through activating JAK/STAT signaling pathway. In addition, double-staining assay could give us a unique perspective from which to study TME in CRC. AJCR
Copyright © 2021.

Entities:  

Keywords:  CRC PTPN2 TAFs migration double staining

Year:  2021        PMID: 34249446      PMCID: PMC8263690     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  20 in total

1.  Modulation of STAT3 phosphorylation by PTPN2 inhibits naïve pluripotency of embryonic stem cells.

Authors:  Yan Zhang; Huiwen Ding; Xiaohu Wang; Shou-Dong Ye
Journal:  FEBS Lett       Date:  2018-06-08       Impact factor: 4.124

2.  Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP.

Authors:  Elina Mattila; Teijo Pellinen; Jonna Nevo; Karoliina Vuoriluoto; Antti Arjonen; Johanna Ivaska
Journal:  Nat Cell Biol       Date:  2004-12-12       Impact factor: 28.824

3.  Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.

Authors:  Lucia Borriello; Rie Nakata; Michael A Sheard; G Esteban Fernandez; Richard Sposto; Jemily Malvar; Laurence Blavier; Hiroyuki Shimada; Shahab Asgharzadeh; Robert C Seeger; Yves A DeClerck
Journal:  Cancer Res       Date:  2017-07-07       Impact factor: 12.701

4.  Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.

Authors:  Marion Alcantara; Mathieu Simonin; Ludovic Lhermitte; Aurore Touzart; Marie Emilie Dourthe; Mehdi Latiri; Nathalie Grardel; Jean Michel Cayuela; Yves Chalandon; Carlos Graux; Hervé Dombret; Norbert Ifrah; Arnaud Petit; Elizabeth Macintyre; André Baruchel; Nicolas Boissel; Vahid Asnafi
Journal:  Blood Adv       Date:  2019-07-09

Review 5.  The role of T-cell protein tyrosine phosphatase in epithelial carcinogenesis.

Authors:  Liza D Morales; Anna K Archbold; Serena Olivarez; Thomas J Slaga; John DiGiovanni; Dae Joon Kim
Journal:  Mol Carcinog       Date:  2019-07-01       Impact factor: 4.784

Review 6.  TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.

Authors:  Kelly A Pike; Michel L Tremblay
Journal:  Cytokine       Date:  2016-01-23       Impact factor: 3.861

7.  Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.

Authors:  Mingyao Meng; Wenju Wang; Jun Yan; Jing Tan; Liwei Liao; Jianlin Shi; Chuanyu Wei; Yanhua Xie; Xingfang Jin; Li Yang; Qing Jin; Huirong Zhu; Weiwei Tan; Fang Yang; Zongliu Hou
Journal:  Tumour Biol       Date:  2016-02-03

8.  TCPTP Regulates Insulin Signaling in AgRP Neurons to Coordinate Glucose Metabolism With Feeding.

Authors:  Garron T Dodd; Robert S Lee-Young; Jens C Brüning; Tony Tiganis
Journal:  Diabetes       Date:  2018-04-30       Impact factor: 9.461

9.  STAT3-mediated IGF-2 secretion in the tumour microenvironment elicits innate resistance to anti-IGF-1R antibody.

Authors:  Ji-Sun Lee; Ju-Hee Kang; Hye-Jin Boo; Su-Jung Hwang; Sungyoul Hong; Su-Chan Lee; Young-Jun Park; Tae-Moon Chung; Hyewon Youn; Seung Mi Lee; Byoung Jae Kim; June-Key Chung; Yeonseok Chung; William N William; Young Kee Shin; Hyo-Jong Lee; Seung-Hyun Oh; Ho-Young Lee
Journal:  Nat Commun       Date:  2015-10-14       Impact factor: 14.919

10.  PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.

Authors:  Elin Karlsson; Cynthia Veenstra; Jon Gårsjö; Bo Nordenskjöld; Tommy Fornander; Olle Stål
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-04       Impact factor: 4.553

View more
  2 in total

1.  Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells.

Authors:  Valentina Mele; Camilla Basso; Valeria Governa; Jesus F Glaus Garzon; Manuele G Muraro; Silvio Däster; Christian A Nebiker; Robert Mechera; Martin Bolli; Alexander Schmidt; Roger Geiger; Giulio C Spagnoli; Dimitri Christoforidis; Pietro E Majno; Lubor Borsig; Giandomenica Iezzi
Journal:  Cancers (Basel)       Date:  2022-04-16       Impact factor: 6.575

Review 2.  PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.

Authors:  Jiachun Song; Jinxin Lan; Jiaping Tang; Na Luo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.